Does the NHS offer weight loss injections — and who actually qualifies?

The biggest misconception: 'If my BMI qualifies, the NHS will prescribe it'

This is the most common misunderstanding our prescribers encounter, and it is understandable given how much press these medicines have received. The truth is that NICE approval and NHS availability are different things. NICE has recommended both tirzepatide and semaglutide for weight management, but the NHS is rolling out access in carefully managed phases, not all at once.

As of June 2025, tirzepatide on the NHS is restricted to adults with a BMI of 40 or above who have four or more of five specific conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. That is a very narrow group. From around June 2026, a second cohort opened, BMI 35 to 39.9 with four or more of those same conditions. A further expansion to three conditions is expected around March 2027. Semaglutide (Wegovy) is available via NHS specialist weight management services under a separate NICE recommendation, though waiting lists through those services are commonly long. NHS England's weight management injections guidance sets out the full criteria in plain terms.

BMI thresholds are reduced by 2.5 kg/m² for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. And every qualifying patient must take part in wrap-around diet and activity support, meeting the criteria on paper does not guarantee a prescription automatically.

What the NHS actually provides when you do qualify

If you qualify through an NHS route, your GP practice may be able to prescribe tirzepatide directly under a new 2026 contract arrangement, though GP participation is optional, so provision varies by area. You would receive the medicine alongside structured lifestyle support. Semaglutide through a specialist service comes with multidisciplinary input as a condition of the NICE recommendation, it is licensed for up to two years in that setting.

What the NHS does not provide is a fast track. People who meet current criteria may still find their local ICB is working through demand, and those who just miss the thresholds (say, a BMI of 38 with three conditions rather than four) are not eligible under current rules regardless of their clinical picture. If you are weighing up your options, reading through NHS weight loss injections reviews from real patients can help set realistic expectations about timelines and outcomes. The detailed breakdown of NHS eligibility covers exactly which conditions count and how the phases work.

It is worth understanding that Scotland, Wales and Northern Ireland operate their own access frameworks. Criteria differ, timelines differ, and if you are based in Scotland the NHS Inform page on weight-loss medication gives locally specific detail.

Private prescription: the legal alternative, explained plainly

For adults who either do not meet NHS thresholds or simply do not want to wait, a private prescription from a regulated UK service is a straightforward legal route. The licensed eligibility criteria are broader than the NHS's phased ones, adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high cholesterol, hypertension, prediabetes or obstructive sleep apnoea, may qualify. A prescriber assesses the full picture, not just a number.

The key is choosing a pharmacy you can verify. The GPhC maintains a public register of every registered pharmacy in the UK at pharmacyregulation.org; any legitimate online service will appear there. If it does not, walk away. There is a genuine problem with fake pens being sold through social media and unofficial channels, the MHRA has seized large quantities of counterfeit weight-loss medicines and urges people to report suspect sellers at yellowcard.mhra.gov.uk.

At nume, our GPhC-registered pharmacy (registration 9012878) dispenses only through licensed UK supply chains. Consultations are reviewed the same day by a real prescriber, not an automated system. Orders placed by noon on a weekday are dispatched the same day once clinically approved, arriving the next working day in plain, unbranded packaging, useful if you need to be in for the DPD driver before the afternoon pickup.

For a broader look at how the private route compares to waiting for NHS access, the weight loss injections overview covers both medicines side by side.

Choosing based on your situation, not a shortcut

These medicines work best alongside dietary changes and regular movement. Neither injection is a replacement for clinical support, and that holds whether your prescription comes via the NHS or a pharmacy near you offering weight loss injections. A prescriber should know your full medical history, current medications and what you are trying to achieve before any treatment starts.

If you are on oral contraceptives and considering tirzepatide, your prescriber needs to know, absorption of the pill may be reduced during the first four weeks of treatment and after each dose increase, so an additional contraceptive method is recommended during those windows. HRT users should raise the subject too, since NHS England advises considering transdermal forms while on tirzepatide for the same reason.

The safety profile of these injections is well documented and the clinical trial evidence is substantial. Side effects are real but, for most people, manageable. A clinical conversation is the right place to weigh that up, not a forum or a headline. If you want to understand more about how weight loss injections work within the NHS before making a decision, that page sets out the full picture, and when you are ready to explore a private prescription, check your eligibility with our prescribers, no obligation, no waiting list.